Prophylactic Intravenous Ketorolac for Prevention of Intraventricular Hemorrhage in Preterm Infants < 32 Weeks and < 1500 Grams: A Double-Blind, Randomized, Placebo-Controlled Trial. Acta Med Philipp 2016, 50 (2). https://doi.org/10.47895/amp.v50i2.847.